Skip to main content

Advertisement

SpringerLink
Log in

Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status

  • Diagnostic Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate whether diffusion tensor imaging (DTI) radiomics with machine learning improves the prediction of isocitrate dehydrogenase (IDH) mutation status of lower-grade gliomas beyond radiomic features from conventional MRI and DTI histogram parameters.

Methods

A total of 168 patients with pathologically confirmed lower-grade gliomas were retrospectively enrolled. A total of 158 and 253 radiomic features were extracted from DTI (DTI radiomics) and conventional MRI (T1-weighted image with contrast enhancement, T2-weighted image, and FLAIR [conventional radiomics]), respectively. The random forest models for predicting IDH status were trained with variable combinations as follows: (1) DTI radiomics, (2) conventional radiomics, (3) conventional radiomics + DTI radiomics, and (4) conventional radiomics + DTI histogram. The models were validated with nested cross-validation. The predictive performances of those models were compared by using area under the curve (AUC) from receiver operating characteristic analysis, and 95% confidence interval (CI) was calculated.

Results

Adding DTI radiomics to conventional radiomics significantly improved the accuracy of IDH status subtyping (AUC, 0.900 [95% CI, 0.855–0.945], p = 0.006), whereas adding DTI histogram parameters yielded nonsignificant trend toward improvement (0.869 [95% CI, 0.816–0.922], p = 0.150) compared with the model with conventional radiomics alone (0.835 [95% CI, 0.773–0.896]). The performance of the model consisting of both DTI and conventional radiomics was significantly superior than that of model consisting of both DTI histogram parameters and conventional radiomics (0.900 vs 0.869, p = 0.040).

Conclusion

DTI radiomics with machine learning can help improve the subtyping of IDH status beyond conventional radiomics and DTI histogram parameters in patients with lower-grade gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hess KR, Broglio KR, Bondy ML (2004) Adult glioma incidence trends in the United States, 1977–2000. Cancer 101:2293–2299

    PubMed  Google Scholar 

  2. Aibaidula A, Chan AK-Y, Shi Z et al (2017) Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro-Oncology 19:1327–1337

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Network TCGAR (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498

    Google Scholar 

  4. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

    PubMed  Google Scholar 

  5. Jiao Y, Killela PJ, Reitman ZJ et al (2012) Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget 3:709–722

    PubMed  PubMed Central  Google Scholar 

  6. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Metellus P, Coulibaly B, Colin C, de Paula AM, Vasiljevic A, Taieb D, Barlier A, Boisselier B, Mokhtari K, Wang XW, Loundou A, Chapon F, Pineau S, Ouafik L, Chinot O, Figarella-Branger D (2010) Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathol 120:719–729

    PubMed  Google Scholar 

  8. Reuss DE, Kratz A, Sahm F, Capper D, Schrimpf D, Koelsche C, Hovestadt V, Bewerunge-Hudler M, Jones DT, Schittenhelm J, Mittelbronn M, Rushing E, Simon M, Westphal M, Unterberg A, Platten M, Paulus W, Reifenberger G, Tonn JC, Aldape K, Pfister SM, Korshunov A, Weller M, Herold-Mende C, Wick W, Brandner S, von Deimling A (2015) Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130:407–417

    CAS  PubMed  Google Scholar 

  9. Yu J, Shi Z, Lian Y, Li Z, Liu T, Gao Y, Wang Y, Chen L, Mao Y (2017) Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Eur Radiol 27:3509–3522

    PubMed  Google Scholar 

  10. Park YW, Han K, Ahn SS, Choi YS, Chang JH, Kim SH, Kang SG, Kim EH, Lee SK (2018) Whole-tumor histogram and texture analyses of DTI for evaluation of IDH1-mutation and 1p/19q-codeletion status in World Health Organization grade II gliomas. AJNR Am J Neuroradiol 39:693–698

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Zhang B, Chang K, Ramkissoon S, Tanguturi S, Bi WL, Reardon DA, Ligon KL, Alexander BM, Wen PY, Huang RY (2017) Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro-Oncology 19:109–117

    CAS  PubMed  Google Scholar 

  12. Yamashita K, Hiwatashi A, Togao O, Kikuchi K, Hatae R, Yoshimoto K, Mizoguchi M, Suzuki SO, Yoshiura T, Honda H (2016) MR imaging-based analysis of glioblastoma multiforme: estimation of IDH1 mutation status. AJNR Am J Neuroradiol 37:58–65

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006

    CAS  PubMed  Google Scholar 

  14. Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, Forster K, Aerts HJ, Dekker A, Fenstermacher D, Goldgof DB, Hall LO, Lambin P, Balagurunathan Y, Gatenby RA, Gillies RJ (2012) Radiomics: the process and the challenges. Magn Reson Imaging 30:1234–1248

    PubMed  PubMed Central  Google Scholar 

  15. Kickingereder P, Gotz M, Muschelli J et al (2016) Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Clin Cancer Res 22:5765–5771

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Kickingereder P, Burth S, Wick A et al (2016) Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models. Radiology 280:880–889

    PubMed  Google Scholar 

  17. Suh HB, Choi YS, Bae S, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Lee SK (2018) Primary central nervous system lymphoma and atypical glioblastoma: differentiation using radiomics approach. Eur Radiol 28:3832–3839. https://doi.org/10.1007/s00330-018-5368-4

    Article  PubMed  Google Scholar 

  18. Kang D, Park JE, Kim YH, Kim JH, Oh JY, Kim J, Kim Y, Kim ST, Kim HS (2018) Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation. Neuro-Oncology. https://doi.org/10.1093/neuonc/noy021

    PubMed  PubMed Central  Google Scholar 

  19. Hilario A, Ramos A, Perez-Nunez A, Salvador E, Millan JM, Lagares A, Sepulveda JM, Gonzalez-Leon P, Hernandez-Lain A, Ricoy JR (2012) The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas. AJNR Am J Neuroradiol 33:701–707

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Choi YS, Ahn SS, Kim DW, Chang JH, Kang SG, Kim EH, Kim SH, Rim TH, Lee SK (2016) Incremental prognostic value of ADC histogram analysis over MGMT promoter methylation status in patients with glioblastoma. Radiology 281:175–184

    PubMed  Google Scholar 

  21. Han Y, Yan LF, Wang XB et al (2018) Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis. BMC Cancer 18:215

    PubMed  PubMed Central  Google Scholar 

  22. Tan WL, Huang WY, Yin B, Xiong J, Wu JS, Geng DY (2014) Can diffusion tensor imaging noninvasively detect IDH1 gene mutations in astrogliomas? A retrospective study of 112 cases. AJNR Am J Neuroradiol 35:920–927

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Brynolfsson P, Nilsson D, Henriksson R, Hauksson J, Karlsson M, Garpebring A, Birgander R, Trygg J, Nyholm T, Asklund T (2014) ADC texture--an imaging biomarker for high-grade glioma? Med Phys 41:101903

    PubMed  Google Scholar 

  24. Eichinger P, Alberts E, Delbridge C et al (2017) Diffusion tensor image features predict IDH genotype in newly diagnosed who grade II/III gliomas. Sci Rep 7:13396

    PubMed  PubMed Central  Google Scholar 

  25. Lu CF, Hsu FT, Hsieh KL et al (2018) Machine learning-based radiomics for molecular subtyping of gliomas. Clin Cancer Res. https://doi.org/10.1158/1078-0432.Ccr-17-3445

    PubMed  Google Scholar 

  26. Qin L, Li A, Qu J, Reinshagen K, Li X, Cheng S-C, Bryant A, Young GS (2018) Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG). J Neuro-Oncol 137:313–319

    Google Scholar 

  27. Cha J, Kim ST, Kim HJ, Kim BJ, Kim YK, Lee JY, Jeon P, Kim KH, Kong DS, Nam DH (2014) Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis. AJNR Am J Neuroradiol 35:1309–1317

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Shinohara RT, Sweeney EM, Goldsmith J, Shiee N, Mateen FJ, Calabresi PA, Jarso S, Pham DL, Reich DS, Crainiceanu CM (2014) Statistical normalization techniques for magnetic resonance imaging. Neuroimage Clin 6:9–19

    PubMed  PubMed Central  Google Scholar 

  29. van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e107

    PubMed  PubMed Central  Google Scholar 

  30. Takano S, Tian W, Matsuda M, Yamamoto T, Ishikawa E, Kaneko MK, Yamazaki K, Kato Y, Matsumura A (2011) Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing. Brain Tumor Pathol 28:115–123

    CAS  PubMed  Google Scholar 

  31. Choi J, Lee EY, Shin KJ, Minn YK, Kim J, Kim SH (2013) IDH1 mutation analysis in low cellularity specimen: a limitation of diagnostic accuracy and a proposal for the diagnostic procedure. Pathol Res Pract 209:284–290

    CAS  PubMed  Google Scholar 

  32. Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G (2010) Molecular diagnostics of gliomas: state of the art. Acta Neuropathol 120:567–584

    CAS  PubMed  PubMed Central  Google Scholar 

  33. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845

    CAS  PubMed  Google Scholar 

  34. Kuhn M (2008) Building predictive models in R using the caret package. J Stat Softw 28:26

    Google Scholar 

  35. Zolal A, Juratli TA, Linn J, Podlesek D, Sitoci Ficici KH, Kitzler HH, Schackert G, Sobottka SB, Rieger B, Krex D (2016) Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery. J Neuro-Oncol 127:551–557

    CAS  Google Scholar 

  36. Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Lada P, Prados M, Goldin J, Wen PY, Cloughesy T (2012) Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neuro-Oncol 108:491–498

    CAS  Google Scholar 

  37. Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B, Ganeshan B, Miles KA, Cook GJ, Goh V (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3:573–589

    PubMed  PubMed Central  Google Scholar 

  38. Ryu YJ, Choi SH, Park SJ, Yun TJ, Kim JH, Sohn CH (2014) Glioma: application of whole-tumor texture analysis of diffusion-weighted imaging for the evaluation of tumor heterogeneity. PLoS One 9:e108335

    PubMed  PubMed Central  Google Scholar 

  39. Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Cheshier SH, Napel S, Zaharchuk G, Plevritis SK (2015) Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology 276:313

    PubMed  Google Scholar 

  40. Li Y, Liu X, Qian Z, Sun Z, Xu K, Wang K, Fan X, Zhang Z, Li S, Wang Y, Jiang T (2018) Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature. Eur Radiol 28:2960–2968

    PubMed  Google Scholar 

  41. Chaddad A, Daniel P, Desrosiers C, Toews M, Abdulkarim B (2019) Novel radiomic features based on joint intensity matrices for predicting glioblastoma patient survival time. IEEE J Biomed Health Inform 23:795–804

    PubMed  Google Scholar 

  42. Bahrami N, Hartman SJ, Chang YH, Delfanti R, White NS, Karunamuni R, Seibert TM, Dale AM, Hattangadi-Gluth JA, Piccioni D, Farid N, McDonald C (2018) Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics. J Neuro-Oncol 139:633–642

    CAS  Google Scholar 

  43. Qi S, Yu L, Li H, Ou Y, Qiu X, Ding Y, Han H, Zhang X (2014) Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms. Oncol Lett 7:1895–1902

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No funding was received.

Author information

Authors and Affiliations

  1. Department of Radiology and Research Institute of Radiological Science, College of Medicine, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Korea

    Chae Jung Park, Yoon Seong Choi, Sung Soo Ahn & Seung-Koo Lee

  2. Department of Radiology, College of Medicine, Ewha Womans University, Seoul, Korea

    Yae Won Park

  3. Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, Korea

    Seok-Gu Kang & Jong-Hee Chang

  4. Department of Pathology, College of Medicine, Yonsei University, Seoul, Korea

    Se Hoon Kim

Authors
  1. Chae Jung Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoon Seong Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yae Won Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sung Soo Ahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seok-Gu Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jong-Hee Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Se Hoon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Seung-Koo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoon Seong Choi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. As this is a retrospective study, formal consent is not required.

Informed consent

The requirement for informed consent was waived due to retrospective nature of the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(PDF 211 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, C.J., Choi, Y.S., Park, Y.W. et al. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status. Neuroradiology 62, 319–326 (2020). https://doi.org/10.1007/s00234-019-02312-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-019-02312-y

Keywords

Search

Navigation